Literature DB >> 23152570

Commentary: Substandard medicines are the priority for neglected tropical diseases.

Thomas P C Dorlo1, Raffaella M Ravinetto, Jos H Beijnen, Marleen Boelaert.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23152570     DOI： 10.1136/bmj.e7518

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.

Authors:  Tim K Mackey; Bryan A Liang; Raphael Cuomo; Ryan Hafen; Kimberly C Brouwer; Daniel E Lee
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment.

Authors:  Tim K Mackey; Bryan A Liang; Peter York; Thomas Kubic
Journal:  Am J Trop Med Hyg       Date:  2015-04-20       Impact factor: 2.345

3.  Substandard and counterfeit medicines: a systematic review of the literature.

Authors:  Tariq Almuzaini; Imti Choonara; Helen Sammons
Journal:  BMJ Open       Date:  2013-08-17       Impact factor: 2.692

4.  A Cross-Sectional Investigation of the Quality of Selected Medicines for Noncommunicable Diseases in Private Community Drug Outlets in Cambodia during 2011-2013.

Authors:  Mohammad Sofiqur Rahman; Naoko Yoshida; Hirohito Tsuboi; Uy Sokchamroeun; Tep Keila; Tey Sovannarith; Heng Bun Kiet; Eav Dararath; Yoshio Akimoto; Tsuyoshi Tanimoto; Kazuko Kimura
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

5.  A tiered analytical approach for investigating poor quality emergency contraceptives.

Authors:  María Eugenia Monge; Prabha Dwivedi; Manshui Zhou; Michael Payne; Chris Harris; Blaine House; Yvonne Juggins; Peter Cizmarik; Paul N Newton; Facundo M Fernández; David Jenkins
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.